ArticleDiscover oncology2025

A comparison of the survival outcome of paclitaxel liposome-based chemoradiotherapy with or without rhEndostatin for unresectable esophageal squamous cell carcinoma: a retrospective study.

Mengyuan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.